|By Marketwired .||
|June 23, 2014 06:30 AM EDT||
DRAPER, UT -- (Marketwired) -- 06/23/14 -- Nutranomics (OTCBB: NNRX), U.S. manufacturer of high quality, whole food based vitamins and supplements designed to support people aiming for a healthy lifestyle and aid those suffering from various diseases is now reaching greater availability with the product release onto Amazon.com, the world's largest online marketplace.
As ninety-five percent of all multi-vitamins on the market today are isolated and/or synthetic, more and more people are searching for a natural, healthy alternative. Nutranomics offers an effective market alternative, one focused on total overall health.
Nutranomics is now available through Amazon at www.amazon.com.
To learn more about Nutranomics supplements, visit http://www.nutranomics.com
Nutranomics has been at the forefront of research and development of nutritional food products since its inception in 1995. At present, we are one of the leading brands in the manufacture of safe, high quality vitamins and supplements distributed in various countries around the world. More than just a health supplement manufacturer, we also see our role in supporting the worldwide community of people aiming for a healthy lifestyle.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's expectation that the products mentioned will continue to be steady sellers for the client and that the client will place additional product re-orders. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.
These statements have not been evaluated by the Food and Drug Administration. The company's products are not intended to diagnose, treat, cure or prevent any disease.
Please direct inquiries to:
May. 30, 2016 12:00 PM EDT Reads: 788
May. 30, 2016 12:00 PM EDT Reads: 1,485
May. 30, 2016 12:00 PM EDT Reads: 4,106
May. 30, 2016 11:30 AM EDT Reads: 717
May. 30, 2016 11:30 AM EDT Reads: 1,464
May. 30, 2016 11:15 AM EDT Reads: 1,335
May. 30, 2016 11:00 AM EDT Reads: 2,570
May. 30, 2016 10:45 AM EDT Reads: 2,056
May. 30, 2016 10:00 AM EDT Reads: 2,287
May. 30, 2016 09:15 AM EDT Reads: 2,368
May. 30, 2016 09:15 AM EDT Reads: 2,809
May. 30, 2016 09:00 AM EDT Reads: 1,428
May. 30, 2016 08:00 AM EDT Reads: 2,387
May. 30, 2016 07:15 AM EDT Reads: 1,403
May. 30, 2016 07:00 AM EDT Reads: 2,251